Investors need to pay close attention to Colgate-Palmolive (CL) stock based on the movements in the options market lately.

Colgate-Palmolive (CL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Colgate-Palmolive (NYSE:CL – Get Free Report) will likely be posting its quarterly earnings results before the market opens ...

We recently compiled a list of the 10 Best Diversified Dividend Stocks To Buy Now. In this article, we are going to take a ...

Colgate-Palmolive Co (CL) stock saw a decline, ending the day at $88.23 which represents a decrease of $-0.46 or -0.52% from the prior close of $88.69. The stock opened at $88.52 and touched a low of ...

We recently published a list of the 10 Best Soaps and Cleaning Materials Stocks to Invest In. In this article, we are going ...

In a report released today, Cheria Widjaja from DBS maintained a Hold rating on Colgate-Palmolive (CL – Research Report), with a price target ...

In February, the Louisville-based health insurance titan said it would exit the Humana Tower over the next 18 to 24 months ...

Colgate-Palmolive (NYSE:CL – Get Free Report) was downgraded by StockNews.com from a “buy” rating to a “hold” rating in a ...

Faces Adjusted Targets Amid Analyst Shifts ...

Colgate-Palmolive Co. closed $22.20 short of its 52-week high ($109.30), which the company reached on September 5th.